Donald W. Glazer

Board Director

Director

US·SEC (Form 4)

BeiGene, Ltd.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 07 Jun 2024 for BeiGene, Ltd.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Donald W. Glazer: trading record in brief

All filings by Donald W. Glazer on record concern BeOne Medicines Ltd., in the capacity of board member. The record holds 8 filings, for trades running from 27 May 2021 to 5 June 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 7 June 2024, the filings show a share grant in BeOne Medicines Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.